Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 22, 2013 - Issue 3
Submit an article Journal homepage
306
Views
5
CrossRef citations to date
0
Altmetric
Reviews

Investigational therapies targeted to the treatment of benign prostatic hyperplasia

Stavros GravasUniversity of Thessalia, Department of Urology, Larissa, Greece
&
Jean JMCH de la RosetteUniversity of Amsterdam, AMC University Hospital, Academic Medical Center, Department of Urology, Meibergdreef 9, 1105 AZ Amsterdam Z-O, The Netherlands+31 20 5666030; +31 20 5669585; [email protected]
Pages 357-368 | Published online: 15 Jan 2013

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Dominique Thomas, Bilal Chughtai, Mitali Kini & Alexis Te. (2017) Emerging drugs for the treatment of benign prostatic hyperplasia. Expert Opinion on Emerging Drugs 22:3, pages 201-212.
Read now
Kanika Gupta, Mona Yezdani, Tiffany Sotelo & Jeanny B Aragon-Ching. (2015) A synopsis of drugs currently in preclinical and early clinical development for the treatment of benign prostatic hyperplasia. Expert Opinion on Investigational Drugs 24:8, pages 1059-1073.
Read now
Rajnish Kumar, Priyanka Malla & Manoj Kumar. (2013) Advances in the design and discovery of drugs for the treatment of prostatic hyperplasia. Expert Opinion on Drug Discovery 8:8, pages 1013-1027.
Read now

Articles from other publishers (2)

Galal H. Elgemeie, Rasha A. Azzam, Wafaa A. Zaghary, Ashraf A. Aly, Nadia H. Metwally, Mona O. Sarhan, Elshimaa M. Abdelhafez & Rasha E. Elsayed. 2022. N-Sulfonated-N-Heterocycles. N-Sulfonated-N-Heterocycles 447 496 .
Maria Geitona, Pinelopi Karabela, Ioannis A Katsoulis, Hara Kousoulakou, Eleni Lyberopoulou, Eleftherios Bitros, Loukas Xaplanteris & Sotiria Papanicolaou. (2014) Dutasteride plus Tamsulosin fixed-dose combination first-line therapy versus Tamsulosin Monotherapy in the treatment of benign prostatic hyperplasia: a budget impact analysis in the Greek healthcare setting. BMC Urology 14:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.